Selective macrophage inhibition abolishes warfarin-induced reduction of metastasis.
D000818:Animals; D002351:Carrageenan / Q000494:pharmacology; D008175:Lung Neoplasms / Q000517:prevention & control / Q000556:secondary*; D008264:Macrophages / Q000187:drug effects; D008297:Male; D051379:Mice; D009374:Neoplasms, Experimental / Q000517:prevention & control; D012822:Silicon Dioxide / Q000494:pharmacology; D014859:Warfarin / Q000037:antagonists & inhibitors / Q000627:therapeutic use*
D014859:Warfarin; D012822:Silicon Dioxide; D002351:Carrageenan